Our knowledge on the impact and outcomes of dysglycemia on the infant brain are still partial and are almost all derived from studies performed on children diagnosed with T1D, a disease characterized also by insulin alteration and episodes of hyperketonemia. This evidence concerns the gene INS and type 1 diabetes mellitus.